ELEV
Price
$0.39
Change
+$0.01 (+2.63%)
Updated
Jul 3 closing price
Capitalization
22.99M
31 days until earnings call
PYPD
Price
$3.50
Change
+$0.01 (+0.29%)
Updated
Jul 3 closing price
Capitalization
35.67M
31 days until earnings call
Interact to see
Advertisement

ELEV vs PYPD

Header iconELEV vs PYPD Comparison
Open Charts ELEV vs PYPDBanner chart's image
Elevation Oncology
Price$0.39
Change+$0.01 (+2.63%)
Volume$540.23K
Capitalization22.99M
PolyPid
Price$3.50
Change+$0.01 (+0.29%)
Volume$82.45K
Capitalization35.67M
ELEV vs PYPD Comparison Chart in %
Loading...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELEV vs. PYPD commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELEV is a Hold and PYPD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ELEV: $0.39 vs. PYPD: $3.50)
Brand notoriety: ELEV and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELEV: 36% vs. PYPD: 13%
Market capitalization -- ELEV: $22.99M vs. PYPD: $35.67M
ELEV [@Biotechnology] is valued at $22.99M. PYPD’s [@Biotechnology] market capitalization is $35.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELEV’s FA Score shows that 1 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • ELEV’s FA Score: 1 green, 4 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, both ELEV and PYPD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELEV’s TA Score shows that 7 TA indicator(s) are bullish while PYPD’s TA Score has 4 bullish TA indicator(s).

  • ELEV’s TA Score: 7 bullish, 3 bearish.
  • PYPD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ELEV is a better buy in the short-term than PYPD.

Price Growth

ELEV (@Biotechnology) experienced а +0.78% price change this week, while PYPD (@Biotechnology) price change was -2.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ELEV is expected to report earnings on Aug 06, 2025.

PYPD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYPD($35.7M) has a higher market cap than ELEV($23M). PYPD YTD gains are higher at: 15.132 vs. ELEV (-31.034). PYPD has higher annual earnings (EBITDA): -29.31M vs. ELEV (-41.4M). ELEV has more cash in the bank: 80.7M vs. PYPD (8.04M). PYPD has less debt than ELEV: PYPD (8.83M) vs ELEV (31.3M). ELEV (0) and PYPD (0) have equivalent revenues.
ELEVPYPDELEV / PYPD
Capitalization23M35.7M64%
EBITDA-41.4M-29.31M141%
Gain YTD-31.03415.132-205%
P/E RatioN/AN/A-
Revenue00-
Total Cash80.7M8.04M1,004%
Total Debt31.3M8.83M355%
TECHNICAL ANALYSIS
Technical Analysis
ELEVPYPD
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 27 days ago
74%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 7 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LNKB7.670.14
+1.86%
LINKBANCORP
WM227.103.71
+1.66%
Waste Management
ALIT5.980.06
+1.01%
Alight
MEG22.31-0.09
-0.40%
Montrose Environmental Group
POCI4.83-0.12
-2.42%
Precision Optics Corp

ELEV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELEV has been loosely correlated with TBPH. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ELEV jumps, then TBPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELEV
1D Price
Change %
ELEV100%
+2.46%
TBPH - ELEV
38%
Loosely correlated
+0.90%
AUTL - ELEV
30%
Poorly correlated
+0.85%
ADAP - ELEV
28%
Poorly correlated
+3.14%
AKBA - ELEV
28%
Poorly correlated
-0.28%
XBIO - ELEV
28%
Poorly correlated
-1.33%
More

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+0.29%
ELEV - PYPD
30%
Poorly correlated
+2.46%
MESO - PYPD
28%
Poorly correlated
-1.66%
PRTA - PYPD
25%
Poorly correlated
+1.82%
ASPHF - PYPD
24%
Poorly correlated
N/A
TENX - PYPD
23%
Poorly correlated
+1.22%
More